Načítá se...
Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation
Allopurinol and its active metabolite, oxypurinol are widely used in the treatment of gout and hyperuricemia. They inhibit xanthine oxidase (XO) an enzyme in the purine degradation pathway that converts xanthine to uric acid. This investigation examined the effect of allopurinol and oxypurinol on bo...
Uloženo v:
| Vydáno v: | Exp Cell Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Academic Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4829071/ https://ncbi.nlm.nih.gov/pubmed/26968635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexcr.2016.03.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|